EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CN7 :1h Alleviates Inflammation, Apoptosis and Extracellular Matrix Degradation in Osteoarthritis by Modulating the NF ‐ κB and mTOR Pathways

Chih-Chien Wang iD, Jeng-Wei Lu, Ya-Wun Wu, You-Hsiang Chu, Yi-Jung Ho, Feng-Cheng Liu, Yi-Jen Peng

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Chih-Chien Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Hauptthemen laut MEDLINE: NF-kappa B, Osteoarthritis, Apoptosis, TOR Serine-Threonine Kinases. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Affairs Bureau, Tri-Service General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a degenerative joint disease with a complex aetiology, which includes inflammation, cellular growth dysregulation and extracellular matrix (ECM) degradation. This study investigated the therapeutic potential of a small‐molecule compound, 2‐amino‐4‐(3,4,5‐trimethoxyphenyl)‐4H‐benzo[h]chromene‐3‐carbonitrile (CN7:1h) in modulating these critical biochemical pathways in OA. Cellular models and rat models of OA were used to explore the impact of CN7:1h on the nuclear factor kappa light chain enhancer of activated B cells (NF‐κB) and mechanistic target of rapamycin (mTOR) signalling pathways. Parameters such as autophagy, apoptosis and ECM preservation were evaluated. CN7:1h demonstrated a non‐cytotoxic profile at a concentration as high as 140 μM as confirmed by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay. At a concentration of 5 μM, CN7:1h was shown to inhibit the activation of NF‐κB and mTOR pathways. CN7:1h was also shown to promote autophagy and reduce apoptosis in cellular models. In rat models, CN7:1h facilitated cartilage repair and demonstrating the therapeutic efficacy of this compound. In conclusion, CN7:1h is a promising bioactive compound for the modulation of key biochemical pathways with therapeutic benefits in degenerative conditions, such as OA. Its high bioavailability and lack of cytotoxicity make CN7:1h an excellent candidate for further research aimed at clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BOsteoarthritisApoptosisTOR Serine-Threonine KinasesExtracellular MatrixSignal TransductionInflammationNitrilesAnimalsRatsAutophagyChondrocytesMaleDisease Models, AnimalRats, Sprague-DawleyHumans

Stichwörter der Autor:innen

Osteoarthritischondrocyteinterleukin‐1βsmall molecule compound

Substanzen

NF-kappa BTOR Serine-Threonine KinasesNitriles

Autor:innen und Institutionen

  • Department of Orthopedics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
  • The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Graduate Institute of Pathology and Parasitology, National Defense Medical Center, Taipei, Taiwan.
  • Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
  • School of Pharmacy, National Defense Medical Center, Taipei, Taiwan.

ORCID-Profile: Chih-Chien Wang

Förderung

  • Medical Affairs Bureau
  • Tri-Service General Hospital

Zitieren

APA

Wang, C. C., Lu, J. W., Wu, Y. W., Chu, Y. H., Ho, Y. J., Liu, F. C., & Peng, Y. J. (2025). CN7 :1h Alleviates Inflammation, Apoptosis and Extracellular Matrix Degradation in Osteoarthritis by Modulating the NF ‐ κB and mTOR Pathways. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70368

Vancouver

Wang CC, Lu JW, Wu YW, Chu YH, Ho YJ, Liu FC, et al. CN7 :1h Alleviates Inflammation, Apoptosis and Extracellular Matrix Degradation in Osteoarthritis by Modulating the NF ‐ κB and mTOR Pathways. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70368

BibTeX
@article{Wang2025,
  author = {Wang, Chih-Chien and Lu, Jeng-Wei and Wu, Ya-Wun and Chu, You-Hsiang and Ho, Yi-Jung and Liu, Feng-Cheng and Peng, Yi-Jen},
  title = {CN7 :1h Alleviates Inflammation, Apoptosis and Extracellular Matrix Degradation in Osteoarthritis by Modulating the NF ‐ κB and mTOR Pathways},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70368}
}
Kostenlos starten →